首页|MSCT定量参数对骨巨细胞瘤定性的诊断价值及与临床预后的关系

MSCT定量参数对骨巨细胞瘤定性的诊断价值及与临床预后的关系

扫码查看
目的 探究多层螺旋CT增强扫描(MSCT)定量参数对骨巨细胞瘤定性的诊断价值及与临床预后的关系.方法 选取2015年1月~2021年1月我院80例骨巨细胞瘤患者作为观察组,另选取同期收治非骨巨细胞瘤的溶骨性骨肿瘤或肿瘤样病变患者80例作为对照组.比较两组MSCT定量参数,分析MSCT定量参数对骨巨细胞瘤定性的诊断价值;比较不同预后患者临床资料、MSCT定量参数,分析MSCT定量参数与骨巨细胞瘤患者临床病理特征的关系,骨巨细胞瘤患者临床预后影响因素.结果 相较于增强前平扫CT值,两组增强后CT值均有升高(P<0.05);观察组增强前平扫CT值、增强后CT值及CT增加值均明显高于对照组(P<0.05);绘制增强前平扫CT值、增强后CT值及CT增加值诊断的受检者工作特征(ROC)曲线,结果显示三者诊断AUC值均在0.7以上,且联合诊断AUC值>0.9,大于各指标单独诊断,差异有统计学意义(P<0.05);复发与未复发患者在肿瘤直径、临床分期、手术方式、Campanicci's放射线分级、增强前平扫CT值、增强后CT值及CT增加值方面比较,差异有统计学意义(P<0.05);骨巨细胞瘤患者增强前平扫CT值、增强后CT值及CT增加值均与肿瘤直径、临床分期及Campanicci's放射线分级呈正相关关系(P<0.05);肿瘤直径、临床分期、手术方式、Campanicci's放射线分级、增强前平扫CT值、增强后CT值及CT增加值均与骨巨细胞瘤患者临床预后密切相关(P<0.05).结论 骨巨细胞瘤患者MSCT检查CT值明显较高,在骨巨细胞瘤定性诊断中具有良好的诊断效能,如结合肿瘤直径、临床分期等因素进行预判,可提示术后复发,为临床工作提供参考依据.
Diagnostic Value of Quantitative MSCT Parameters for the Characterization of Giant Cell Tumor of Bone and the Relationship with Clinical Prognosis
Objective To investigate the diagnostic value of quantitative parameters of multilayer spiral CT-enhanced scanning(MSCT)for the characterization of giant cell tumor of bone and the relationship with clinical prognosis.Methods Eighty patients with giant cell tumor of bone in our hospital from January 2019 to January 2021 were selected as the observation group,and another 80 patients with hemolytic tumor or tumorigenic lesions who were not giant cell tumor of bone admitted in the same period were selected as the control group.To compare the quantitative parameters of MSCT between the two groups and analyze the diagnostic value of quantitative parameters of MSCT for the characterization of giant cell tumor of bone;to compare the clinical data and quantitative parameters of MSCT of patients with different prognosis,to analyze the relationship between quantitative parameters of MSCT and clinicopathological characteristics of patients with giant cell tumor of bone,and the factors influencing the clinical prognosis of patients with giant cell tumor of bone.Results Compared with the preenhancement plain CT values,the postenhancement CT values of both groups were significantly higher,and the difference was statistically significant(P<0.05);the preenhancement plain CT values,postenhancement CT values and CT increase values of the observation group were significantly higher than those of the control group,and the difference was statistically significant(P<0.05).Plotting the subject operating characteristic(ROC)curves for the diagnosis of giant cell tumor of bone with preenhanced plain CT value,postenhanced CT value and CT increased value,the results showed that all three diagnostic AUC values were above 0.7,and the combined diagnostic AUC value was>0.9,which was greater than each index alone,and the difference was statistically significant(P<0.05).Statistically significant differences(P<0.05)were found between recurrent and non-recurrent patients in terms of tumor diameter,clinical stage,surgical approach,Campanicci's radiographic grading,plain CT values before enhancement,CT values after enhancement and CT increase.The preenhanced plain CT values,postenhanced CT values and CT increase values of patients with giant cell tumor of bone were positively correlated with tumor diameter,clinical stage and Campanicci's radiographic grade(P<0.05);tumor diameter,clinical stage,surgical method,Campanicci's radiographic grade,preenhanced plain CT values,postenhanced CT values and CT increase values were closely correlated with the clinical prognosis of patients with giant cell tumor of bone(P<0.05).The clinical prognosis of patients with giant cell tumor was strongly correlated(P<0.05).Conclusion The CT value of MSCT examination in patients with giant cell tumor of bone is significantly higher,which has good diagnostic efficacy in the qualitative diagnosis of giant cell tumor of bone,and can suggest postoperative recurrence if combined with tumor diameter,clinical stage and other factors for prognosis,providing a reference basis for clinical work.

Giant Cell Tumor of BoneMSCT ExaminationQualitative DiagnosisClinical Prognosis

武粟、王仁贵

展开 >

北京水利医院医学影像科(北京 100036)

首都医科大学附属北京世纪坛医院放射中心(北京 100036)

骨巨细胞瘤 MSCT检查 定性诊断 临床预后

北京市卫生科技发展专项基金

2019-2-672

2024

中国CT和MRI杂志
北京大学深圳临床医学院 北京大学第一医院

中国CT和MRI杂志

CSTPCD
影响因子:1.578
ISSN:1672-5131
年,卷(期):2024.22(1)
  • 10